EON
Commercial- Indications
- Fat reduction, Body contouring
Company intelligence / Profile preview
EON by Dominion Aesthetic Technologies is an FDA-cleared 1064 nm robotic laser device for non-contact fat reduction. It uses a combination of high-powered diode lasers and jet-inspired cooling to induce apoptosis in adipose tissue while maintaining patient comfort. Clinical use has demonstrated effective fat reduction on the abdomen and other areas with minimal discomfort or downtime. The system’s autonomous mapping allows for personalized treatments without direct skin contact or post-procedure massages.
The company has raised over $23 million in funding to accelerate manufacturing and commercialization efforts.
Select plastic surgery and dermatology practices across the U.S. are using EON commercially.
No major adverse events reported; clinical results show significant localized fat loss.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dominion Aesthetic Technologies.